1 / 6

In-Vitro Colorectal Cancer Screening Tests Market to see growth of over 5.0% from 2017 to 2024

Get more details @ https://bit.ly/2dDSSX8 <br>Growing incidences of colorectal cancer globally along with rising disease awareness due to numerous initiatives undertaken by public and private players will drive in-vitro colorectal cancer screening tests market.

jueekate
Télécharger la présentation

In-Vitro Colorectal Cancer Screening Tests Market to see growth of over 5.0% from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In-Vitro Colorectal Cancer Screening Tests Market to reach $1bn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from In-vitro Colorectal Cancer Screening Tests Market : • In-Vitro Colorectal Cancer Screening Tests Market size is set to exceed USD 1 billion by 2024; according to a new research report by Global Market Insights. • The colorectal cancer screening has revealed to be effective technique in order to detect early colorectal cancer (CRC) as well as precancerous lesions. • Chronic conditions such as inflammatory bowel disease, and Type 2 diabetes along with sedentary lifestyle, heavy alcohol consumption is on escalation and are related to colorectal cancer. • Inadequate reimbursement coverage coupled with lack of trained staff in the developing regions and dearth of uniform cancer screening guidelines in the Asia Pacific region will hamper business growth. • Fecal occult blood test (FOBT) test type segment dominated the market in 2016, on an account of widely preferred test due to FOBT being inexpensive and non-invasive as compared to sigmoidoscopy and colonoscopy.

  3. Continued... • CRC DNA screening test segment is anticipated to grow at a highest CAGR. • Germany in-vitro colorectal cancer screening tests market is projected to witness robust business growth in foreseeable future. • Italy in-vitro CRC screening tests market is anticipated to exhibit highest CAGR due to increasing risk factors of cancer, coupled with growing elderly population base. • China’s in-vitro colorectal cancer screening tests market will grow significantly as a result of escalating incidences of colorectal cancer and growing initiatives by government for establishing targeted prevention and prior detection programs. • Some of the prominent business players operational in global in-vitro CRC screening tests market are Alere, Abbott Molecular, Eiken Chemical, Beckman Coulter, Epigenomics, Siemens Healthcare, Sysmex, Quest Diagnostics, Exact Sciences, OncoCyte Corporation-Bio time, EMD Millipore, GeneNews, BioMarCare Technologies, Immunostics, Qiagen, Kyowa Medex, Novigenix, Randox Laboratories, and R-Biopharm.

  4. China In-Vitro Colorectal Cancer Screening Tests Market, By Test Type, 2013 - 2024 (USD Million)

  5. Browse Full Market Research Report On In-vitro Colorectal Cancer Screening Tests Market @ http://goo.gl/JHtO1Z Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/451https://www.gminsights.com/request-sample/detail/49

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related